Kaletra 200/50, Filmtabletten - 120 Tablette(n) Swissmedic Key 57555001 Registration Holder AbbVie AG Name Kaletra 200/50, Filmtabletten Date of registration 22.08.2006 Introduction of Sequence 22.08.2006 ATC-Classification Lopinavir and Ritonavir (J05AR10) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 08.03. Show package size 120 Tablette(n) Index Therapeuticus (Swissmedic) 08.03. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 504.99 Limitation No Deductible 10 % Consumer price 565.60 Feedback FB Daily cost GTIN 7680575550013 Medication Code Synthetika Pharmacode 3316264 Disponibility
Composition lopinavirum 200 mg, ritonavirum 50 mg, copovidonum K 28, sorbitani lauras, silica colloidalis anhydrica, natrii stearylis fumaras, Überzug: hypromellosum, macrogolum 400, hydroxypropylcellulosum, talcum, macrogolum 3350, polysorbatum 80, silica colloidalis anhydrica, E 171, E 172 (rubrum), pro compresso obducto corresp. natrium 724 µg. Teilbarkeit Teilbar Keine Bruchrille Auflösbar oder suspendierbar kA Zermörsebar Nein Öffnen von Kapseln -- Bemerkungen / Alternativen Alternative: Kaletra Sirup Quellen
th_part Galenic Form Coated tablets Active Agent Dose Lopinavir 200 mg Ritonavir 50 mg
BAG: Active Agent Dose Lopinavir 200 mg Ritonavir 50 mg
Inactive agents Dose additional_information (Rubrum) Copovidonum K 28 E 171 color. E 172 color. Hydroxypropylcellulosum Hypromellosum Überzug Macrogol 3350 Natrii Stearylis Fumaras Polysorbatum 80 Pro Compresso Obducto Silica Colloidalis Anhydrica Sorbitani Lauras Talcum
Source Data was imported : 06.07.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
